Potent anti-tumor effects of receptor-retargeted syncytial oncolytic herpes simplex virus.

Suzuki, Takuma; Uchida, Hiroaki; Shibata, Tomoko; Sasaki, Yasuhiko; Ikeda, Hitomi; Hamada-Uematsu, Mika; Hamasaki, Ryota; Okuda, Kosaku; Yanagi, Shigeru; Tahara, Hideaki

Suzuki, Takuma; Uchida, Hiroaki; Shibata, Tomoko; Sasaki, Yasuhiko; Ikeda, Hitomi; Hamada-Uematsu, Mika; Hamasaki, Ryota; Okuda, Kosaku; Yanagi, Shigeru; Tahara, Hideaki.

Suzuki T; Project Division of Cancer Biomolecular Therapy, The Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan.
Uchida H; Laboratory of Molecular Biochemistry, School of Life Sciences, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan.
Shibata T; Project Division of Cancer Biomolecular Therapy, The Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan.
Sasaki Y; Project Division of Cancer Biomolecular Therapy, The Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan.
Ikeda H; Project Division of Cancer Biomolecular Therapy, The Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan.
Hamada-Uematsu M; Project Division of Cancer Biomolecular Therapy, The Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan.
Hamasaki R; Project Division of Cancer Biomolecular Therapy, The Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan.
Okuda K; Project Division of Cancer Biomolecular Therapy, The Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan.
Yanagi S; Ono Pharmaceutical Co., Ltd., Osaka, Japan.
Tahara H; Project Division of Cancer Biomolecular Therapy, The Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan.